Title : Nilotinib significantly induces apoptosis in imatinib-resistant K562 cells with wild-type BCR-ABL, as effectively as in parental sensitive counterparts.

Pub. Date : 2010 Feb

PMID : 20132660






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Nilotinib significantly induces apoptosis in imatinib-resistant K562 cells with wild-type BCR-ABL, as effectively as in parental sensitive counterparts. nilotinib ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens
2 Imatinib and nilotinib are chemotherapeutic drugs which specifically bind to the BCR-ABL and inhibit cancer cells. nilotinib ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens
3 We have shown that nilotinib induces apoptosis in imatinib-resistant K562 CML cells which have the wild-type BCR-ABL fusion gene almost to the same extent as it does in the parental sensitive cells by the increase in caspase-3 enzyme activity and the decrease in mitochondrial membrane potential. nilotinib ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens